United States Bovine Vaccines Market Report 2016

Publisher Name :
Date: 13-Sep-2016
No. of pages: 120
Inquire Before Buying

Notes:

Sales, means the sales volume of Bovine Vaccines

Revenue, means the sales value of Bovine Vaccines

This report studies sales (consumption) of Bovine Vaccines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Bayer HealthCare AG (Germany)

- Biogenesis-Bago (Argentina)

- Boehringer Ingelheim GmbH (Germany)

- Ceva Sante Animale (France)

- Heska Corporation (US)

- Indian Immunologicals Ltd (India)

- Lohmann Animal Health (US)

- Merck Animal Health (US)

- Merial Ltd. (US)

- Protein Sciences Corporation (US)

- Virbac SA (France)

- Zoetis Inc. (US)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Bovine virus diarrhoea - Mucosal disease (BVD-MD)

- Johne's disease

- Infectious Bovine Rhinotracheitis (IBR)

- Blackleg

- Neosporosis

Split by applications, this report focuses on sales, market share and growth rate of Bovine Vaccines in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Bovine Vaccines Market Report 2016

Table of Contents
United States Bovine Vaccines Market Report 2016
1 Bovine Vaccines Overview
1.1 Product Overview and Scope of Bovine Vaccines
1.2 Classification of Bovine Vaccines
1.2.1 Bovine virus diarrhoea - Mucosal disease (BVD-MD)
1.2.2 Johne's disease
1.2.3 Infectious Bovine Rhinotracheitis (IBR)
1.2.4 Blackleg
1.2.5 Neosporosis
1.3 Application of Bovine Vaccines
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Bovine Vaccines (2011-2021)
1.4.1 USA Bovine Vaccines Sales and Growth Rate (2011-2021)
1.4.2 USA Bovine Vaccines Revenue and Growth Rate (2011-2021)
2 USA Bovine Vaccines Competition by Manufacturers
2.1 USA Bovine Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Bovine Vaccines Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Bovine Vaccines Average Price by Manufactures (2015 and 2016)
2.4 Bovine Vaccines Market Competitive Situation and Trends
2.4.1 Bovine Vaccines Market Concentration Rate
2.4.2 Bovine Vaccines Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 USA Bovine Vaccines Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 USA Bovine Vaccines Sales and Market Share by Type (2011-2016)
3.2 USA Bovine Vaccines Revenue and Market Share by Type (2011-2016)
3.3 USA Bovine Vaccines Price by Type (2011-2016)
3.4 USA Bovine Vaccines Sales Growth Rate by Type (2011-2016)
4 USA Bovine Vaccines Sales (Volume) by Application (2011-2016)
4.1 USA Bovine Vaccines Sales and Market Share by Application (2011-2016)
4.2 USA Bovine Vaccines Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 USA Bovine Vaccines Manufacturers Profiles/Analysis
5.1 Bayer HealthCare AG (Germany)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Bovine Vaccines Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Bayer HealthCare AG (Germany) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Biogenesis-Bago (Argentina)
5.2.2 Bovine Vaccines Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Biogenesis-Bago (Argentina) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Boehringer Ingelheim GmbH (Germany)
5.3.2 Bovine Vaccines Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Boehringer Ingelheim GmbH (Germany) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Ceva Sante Animale (France)
5.4.2 Bovine Vaccines Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Ceva Sante Animale (France) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Heska Corporation (US)
5.5.2 Bovine Vaccines Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Heska Corporation (US) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Indian Immunologicals Ltd (India)
5.6.2 Bovine Vaccines Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Indian Immunologicals Ltd (India) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Lohmann Animal Health (US)
5.7.2 Bovine Vaccines Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Lohmann Animal Health (US) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Merck Animal Health (US)
5.8.2 Bovine Vaccines Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Merck Animal Health (US) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Merial Ltd. (US)
5.9.2 Bovine Vaccines Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Merial Ltd. (US) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Protein Sciences Corporation (US)
5.10.2 Bovine Vaccines Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Protein Sciences Corporation (US) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Virbac SA (France)
5.12 Zoetis Inc. (US)
6 Bovine Vaccines Manufacturing Cost Analysis
6.1 Bovine Vaccines Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Bovine Vaccines
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Bovine Vaccines Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Bovine Vaccines Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 USA Bovine Vaccines Market Forecast (2016-2021)
10.1 USA Bovine Vaccines Sales, Revenue Forecast (2016-2021)
10.2 USA Bovine Vaccines Sales Forecast by Type (2016-2021)
10.3 USA Bovine Vaccines Sales Forecast by Application (2016-2021)
10.4 Bovine Vaccines Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Bovine Vaccines
Table Classification of Bovine Vaccines
Figure USA Sales Market Share of Bovine Vaccines by Type in 2015
Figure Bovine virus diarrhoea - Mucosal disease (BVD-MD) Picture
Figure Johne's disease Picture
Figure Infectious Bovine Rhinotracheitis (IBR) Picture
Figure Blackleg Picture
Figure Neosporosis Picture
Table Application of Bovine Vaccines
Figure USA Sales Market Share of Bovine Vaccines by Application in 2015
Figure USA Bovine Vaccines Sales and Growth Rate (2011-2021)
Figure USA Bovine Vaccines Revenue and Growth Rate (2011-2021)
Table USA Bovine Vaccines Sales of Key Manufacturers (2015 and 2016)
Table USA Bovine Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Bovine Vaccines Sales Share by Manufacturers
Figure 2016 Bovine Vaccines Sales Share by Manufacturers
Table USA Bovine Vaccines Revenue by Manufacturers (2015 and 2016)
Table USA Bovine Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Bovine Vaccines Revenue Share by Manufacturers
Table 2016 USA Bovine Vaccines Revenue Share by Manufacturers
Table USA Market Bovine Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Bovine Vaccines Average Price of Key Manufacturers in 2015
Figure Bovine Vaccines Market Share of Top 3 Manufacturers
Figure Bovine Vaccines Market Share of Top 5 Manufacturers
Table USA Bovine Vaccines Sales by Type (2011-2016)
Table USA Bovine Vaccines Sales Share by Type (2011-2016)
Figure USA Bovine Vaccines Sales Market Share by Type in 2015
Table USA Bovine Vaccines Revenue and Market Share by Type (2011-2016)
Table USA Bovine Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Bovine Vaccines by Type (2011-2016)
Table USA Bovine Vaccines Price by Type (2011-2016)
Figure USA Bovine Vaccines Sales Growth Rate by Type (2011-2016)
Table USA Bovine Vaccines Sales by Application (2011-2016)
Table USA Bovine Vaccines Sales Market Share by Application (2011-2016)
Figure USA Bovine Vaccines Sales Market Share by Application in 2015
Table USA Bovine Vaccines Sales Growth Rate by Application (2011-2016)
Figure USA Bovine Vaccines Sales Growth Rate by Application (2011-2016)
Table Bayer HealthCare AG (Germany) Basic Information List
Table Bayer HealthCare AG (Germany) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare AG (Germany) Bovine Vaccines Sales Market Share (2011-2016)
Table Biogenesis-Bago (Argentina) Basic Information List
Table Biogenesis-Bago (Argentina) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biogenesis-Bago (Argentina) Bovine Vaccines Sales Market Share (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Basic Information List
Table Boehringer Ingelheim GmbH (Germany) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Bovine Vaccines Sales Market Share (2011-2016)
Table Ceva Sante Animale (France) Basic Information List
Table Ceva Sante Animale (France) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ceva Sante Animale (France) Bovine Vaccines Sales Market Share (2011-2016)
Table Heska Corporation (US) Basic Information List
Table Heska Corporation (US) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Heska Corporation (US) Bovine Vaccines Sales Market Share (2011-2016)
Table Indian Immunologicals Ltd (India) Basic Information List
Table Indian Immunologicals Ltd (India) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Indian Immunologicals Ltd (India) Bovine Vaccines Sales Market Share (2011-2016)
Table Lohmann Animal Health (US) Basic Information List
Table Lohmann Animal Health (US) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lohmann Animal Health (US) Bovine Vaccines Sales Market Share (2011-2016)
Table Merck Animal Health (US) Basic Information List
Table Merck Animal Health (US) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Animal Health (US) Bovine Vaccines Sales Market Share (2011-2016)
Table Merial Ltd. (US) Basic Information List
Table Merial Ltd. (US) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merial Ltd. (US) Bovine Vaccines Sales Market Share (2011-2016)
Table Protein Sciences Corporation (US) Basic Information List
Table Protein Sciences Corporation (US) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Protein Sciences Corporation (US) Bovine Vaccines Sales Market Share (2011-2016)
Table Virbac SA (France) Basic Information List
Table Virbac SA (France) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Virbac SA (France) Bovine Vaccines Sales Market Share (2011-2016)
Table Zoetis Inc. (US) Basic Information List
Table Zoetis Inc. (US) Bovine Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zoetis Inc. (US) Bovine Vaccines Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bovine Vaccines
Figure Manufacturing Process Analysis of Bovine Vaccines
Figure Bovine Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Bovine Vaccines Major Manufacturers in 2015
Table Major Buyers of Bovine Vaccines
Table Distributors/Traders List
Figure USA Bovine Vaccines Production and Growth Rate Forecast (2016-2021)
Figure USA Bovine Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table USA Bovine Vaccines Production Forecast by Type (2016-2021)
Table USA Bovine Vaccines Consumption Forecast by Application (2016-2021)
  • EMEA (Europe, Middle East and Africa) Recombinant Peptides Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 100
    In this report, the EMEA Recombinant Peptides market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Recombinant Peptides for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux;......
  • EMEA (Europe, Middle East and Africa) Oxyclozanide Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 103
    In this report, the EMEA Oxyclozanide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Oxyclozanide for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Middle Ea......
  • EMEA (Europe, Middle East and Africa) Montelukast Sodium Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 111
    In this report, the EMEA Montelukast Sodium market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Montelukast Sodium for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; ......
  • EMEA (Europe, Middle East and Africa) DHA Powder Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 114
    In this report, the EMEA DHA Powder market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of DHA Powder for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Middle East......
  • United States Active Pharma Ingredient Market Report 2017
    Published: 24-Mar-2017        Price: US 3800 Onwards        Pages: 117
    In this report, the United States Active Pharma Ingredient market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth......
  • United States Pharmaceutical Grade Fulvic Acid Market Report 2017
    Published: 24-Mar-2017        Price: US 3800 Onwards        Pages: 99
    In this report, the United States Pharmaceutical Grade Fulvic Acid market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share an......
  • Global Ketoprofen Sales Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 107
    In this report, the global Ketoprofen market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Ketoprofen for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - South......
  • Global Kaempferol Sales Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 103
    In this report, the global Kaempferol market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Kaempferol for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - Southeas......
  • Global Enzyme Inhibitor Sales Market Report 2017
    Published: 24-Mar-2017        Price: US 4000 Onwards        Pages: 100
    In this report, the global Enzyme Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Enzyme Inhibitor for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs